The Central Drugs Standard Control Organisation (CDSCO), through its New Drugs Division, issued a circular dated 21 September 2026 highlighting the risks associated with the indiscriminate use of NSAIDs (painkillers) and antibiotics, particularly in relation to Chronic Kidney Disease (CKD).
Key Points
- NSAIDs and antibiotics are regulated under the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945.
- Most NSAIDs fall under Schedule H, while many antibiotics fall under Schedule H1, requiring prescription-based sale and appropriate warnings.
- The circular advises the public to avoid self-medication and prolonged or repeated use of NSAIDs and antibiotics.
- Healthcare professionals are advised to prescribe these medicines only when clinically indicated and to consider factors such as renal impairment, co-morbidities, age and concomitant medicines.
- Pharmacists, retailers and distributors are directed to comply with applicable prescription and sale requirements.
- Hospitals and healthcare institutions are advised to strengthen prescription review, patient counselling and antimicrobial stewardship.
- State/UT Drug Control Authorities are requested to create awareness regarding the risks associated with inappropriate use.